Cell Growth & Differentiation, Vol 9, Issue 9 731-741, Copyright © 1998 by American Association of Cancer Research

ARTICLES

Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins

CE Nesbit, LE Grove, X Yin and EV Prochownik
Department of Pediatrics, Children's Hospital of Pittsburgh, Pennsylvania 15213, USA.

c-, N-, and L-myc are related nuclear oncoproteins that bind similar DNA sites and cooperate with activated ras oncogenes to transform primary fibroblasts. Although c-myc can also promote apoptosis in some cells after growth factor withdrawal or exposure to cytotoxic agents, roles for N- and L-myc in apoptosis remain undetermined. To address this, c-, N-, or L-myc were stably expressed in the interleukin 3 (IL-3)-dependent 32D hematopoietic cell line. The apoptotic response of each cell line was assessed after IL-3 withdrawal or treatment with four structurally unrelated cytotoxic agents. All three oncoproteins accelerated apoptosis after IL-3 withdrawal. In contrast, whereas c-myc overexpression generally sensitized cells to cytotoxic drugs, N-myc and L-myc overexpression produced resistance. myc expression tended to be associated with a more robust G2-M arrest after drug exposure, but this did not correlate with drug sensitivity or resistance. Bcl-2 and Bcl-X(L) protected control cells against apoptosis after either IL-3 withdrawal or drug exposure, although in some cases this effect could be overridden by myc oncoproteins, particularly N-myc and L-myc. Our results suggest that the apoptotic pathways activated upon IL-3 withdrawal and cytotoxic drug treatment are distinct and differentially affected by members of the myc and Bcl-2 families.

This article has been cited by other articles:

				M. Gostissa, S. Ranganath, J. M. Bianco, and F. W. Alt Chromosomal location targets different MYC family gene members for oncogenic translocations PNAS, February 17, 2009; 106(7): 2265 - 2270. [Abstract] [Full Text] [PDF]

				A. Hachem and R. B. Gartenhaus Oncogenes as molecular targets in lymphoma Blood, September 15, 2005; 106(6): 1911 - 1923. [Full Text] [PDF]

				W. R. Atchley and A. D. Fernandes Sequence signatures and the probabilistic identification of proteins in the Myc-Max-Mad network PNAS, May 3, 2005; 102(18): 6401 - 6406. [Abstract] [Full Text] [PDF]

				F. Yi, R. Jaffe, and E. V. Prochownik The CCL6 Chemokine Is Differentially Regulated by c-Myc and L-Myc, and Promotes Tumorigenesis and Metastasis Cancer Res., June 1, 2003; 63(11): 2923 - 2932. [Abstract] [Full Text] [PDF]

				A. Biroccio, B. Benassi, G. Filomeni, S. Amodei, S. Marchini, G. Chiorino, G. Rotilio, G. Zupi, and M. R. Ciriolo Glutathione Influences c-Myc-induced Apoptosis in M14 Human Melanoma Cells J. Biol. Chem., November 8, 2002; 277(46): 43763 - 43770. [Abstract] [Full Text] [PDF]

				Z. M. Mu, X. Y. Yin, and E. V. Prochownik Pag, a Putative Tumor Suppressor, Interacts with the Myc Box II Domain of c-Myc and Selectively Alters Its Biological Function and Target Gene Expression J. Biol. Chem., November 1, 2002; 277(45): 43175 - 43184. [Abstract] [Full Text] [PDF]

				X. Yin, L. Grove, K. Rogulski, and E. V. Prochownik Myc Target in Myeloid Cells-1, a Novel c-Myc Target, Recapitulates Multiple c-Myc Phenotypes J. Biol. Chem., May 24, 2002; 277(22): 19998 - 20010. [Abstract] [Full Text] [PDF]

				X.-Y. Yin, L. Grove, N. S. Datta, K. Katula, M. W. Long, and E. V. Prochownik Inverse Regulation of Cyclin B1 by c-Myc and p53 and Induction of Tetraploidy by Cyclin B1 Overexpression Cancer Res., September 1, 2001; 61(17): 6487 - 6493. [Abstract] [Full Text] [PDF]

				A. Biroccio, B. Benassi, S. Amodei, C. Gabellini, D. Del Bufalo, and G. Zupi C-Myc Down-Regulation Increases Susceptibility to Cisplatin through Reactive Oxygen Species-Mediated Apoptosis in M14 Human Melanoma Cells Mol. Pharmacol., July 1, 2001; 60(1): 174 - 182. [Abstract] [Full Text]

				H. Primdahl, H. von der Maase, M. Christensen, H. Wolf, and T. F. Ørntoft Allelic Deletions of Cell Growth Regulators during Progression of Bladder Cancer Cancer Res., December 1, 2000; 60(23): 6623 - 6629. [Abstract] [Full Text]

				A. K. Sarkar and J. G. Nuchtern Lysis of MYCN-amplified Neuroblastoma Cells by MYCN Peptide-specific Cytotoxic T Lymphocytes Cancer Res., April 1, 2000; 60(7): 1908 - 1913. [Abstract] [Full Text]

				K. Noguchi, C. Kitanaka, H. Yamana, A. Kokubu, T. Mochizuki, and Y. Kuchino Regulation of c-Myc through Phosphorylation at Ser-62 and Ser-71 by c-Jun N-Terminal Kinase J. Biol. Chem., November 12, 1999; 274(46): 32580 - 32587. [Abstract] [Full Text] [PDF]